Literature DB >> 16650433

Isolation of mesenchymal stem cells from human vermiform appendix.

Paolo De Coppi1, Michela Pozzobon, Martina Piccoli, Maria Vittoria Gazzola, Luisa Boldrin, Elisa Slanzi, Roberta Destro, Luigi Zanesco, Giovanni Franco Zanon, Piergiorgio Gamba.   

Abstract

BACKGROUND: Recent findings have shown that pluripotent stem cells exist in areas outside the bone marrow (BM). Moreover, it has been demonstrated that the appendix is important for the development of mucosal gut immunity, and hematopoietic progenitors have been isolated from animal and human appendices.
MATERIALS AND METHODS: Non-inflamed appendices removed during laparotomy were processed and cultured until the appearance of adherent cells. Differentiations (performed under osteogenic, adipogenic, and myogenic conditions) were confirmed by immunohistochemistry and cytochemistry. Polymerase chain reaction and cytofluorimetric analyses were performed to evidence the presence of genes and protein specific lineages in appendix-derived mesenchymal stem cells (ADMCs).
RESULTS: ADMCs were present in non-inflamed appendices. ADMCs under osteogenic conditions differentiated in osteoblasts and showed increased alkaline phosphatase expression; at the gene level, we observed the expression of Core binding factor alpha 1 (Cbfa1) and osteocalcin in osteogenic induced ADMCs. Under adipogenic conditions, lipidic drops in the cytoplasm, expression of lipoprotein lipase (LpL), and peroxisome proliferator-activated receptor gamma were observed; under myogenic conditions, myotubes expressing muscle specific proteins like desmin were formed. Myogenic regulatory factor 4 and MyoD were selectively induced in the ADMCs under myogenic conditions.
CONCLUSIONS: This study shows for the first time that mesenchymal stem cells can be isolated from normal appendices obtained from a pediatric and adult age group (0-18 years of age). This finding not only may further knowledge of the maturation of the intestinal immunesystem but also could indicate a new physiological role of the human vermiform appendix.

Entities:  

Mesh:

Year:  2006        PMID: 16650433     DOI: 10.1016/j.jss.2006.03.009

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  6 in total

1.  alpha7 integrin expressing human fetal myogenic progenitors have stem cell-like properties and are capable of osteogenic differentiation.

Authors:  Nobuaki Ozeki; Moon Lim; Chung-Chen Yao; Mirek Tolar; Randall H Kramer
Journal:  Exp Cell Res       Date:  2006-09-23       Impact factor: 3.905

2.  Conservative antibiotic treatment for acute uncomplicated appendicitis is feasible.

Authors:  Zvi Steiner; Genady Buklan; Michael Gutermacher; Ita Litmanovitz; Tal Landa; Shmuel Arnon
Journal:  Pediatr Surg Int       Date:  2018-01-17       Impact factor: 1.827

3.  Probing stemness and neural commitment in human amniotic fluid cells.

Authors:  Anna Jezierski; Andree Gruslin; Roger Tremblay; Dao Ly; Cathie Smith; Kursad Turksen; Marianna Sikorska; Mahmud Bani-Yaghoub
Journal:  Stem Cell Rev Rep       Date:  2010-06       Impact factor: 5.739

4.  Non-operative treatment versus appendectomy for acute uncomplicated appendicitis: A randomized controlled trial.

Authors:  Muhammad Nadeem Sajjad; Fatima Naumeri; Sehrish Hina
Journal:  Pak J Med Sci       Date:  2021 Sep-Oct       Impact factor: 1.088

Review 5.  Conservative treatment of acute appendicitis.

Authors:  Federico Coccolini; Paola Fugazzola; Massimo Sartelli; Enrico Cicuttin; Maria Grazia Sibilla; Gioacchino Leandro; Gian Luigi De' Angelis; Federica Gaiani; Francesco Di Mario; Matteo Tomasoni; Fausto Catena; Luca Ansaloni
Journal:  Acta Biomed       Date:  2018-12-17

6.  Tumor-like stem cells derived from human keloid are governed by the inflammatory niche driven by IL-17/IL-6 axis.

Authors:  Qunzhou Zhang; Takayoshi Yamaza; A Paul Kelly; Shihong Shi; Songlin Wang; Jimmy Brown; Lina Wang; Samuel W French; Songtao Shi; Anh D Le
Journal:  PLoS One       Date:  2009-11-11       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.